Gabapentin

Progress in Brain Research

Volumn 166, Issue , 2007, Pages 287-301

  Bauer, Carol A ^a   Brozoski, Thomas J ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acoustic trauma; animal model; clinical trial; GABA; gabapentin; inhibition; tinnitus; vigabatrin

Indexed keywords

4 AMINOBUTYRIC ACID; GABAPENTIN; PLACEBO; VIGABATRIN;

AGING; AUDITORY NERVOUS SYSTEM; CLINICAL TRIAL; DOWN REGULATION; DRUG ACTIVITY; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; HUMAN; NEUROTRANSMISSION; NOISE INJURY; NONHUMAN; PRIORITY JOURNAL; REVIEW; TINNITUS;

AMINES; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; EXCITATORY AMINO ACID ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; TINNITUS;

EID: 35348926096     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(07)66027-0     Document Type: Review

References (36)

1. Al-Mujadi H., AR A.R., Katzarov M.G., Dehrab N.A., Batra Y.K., and Al-Qattan A.R. Preemptive gabapentin reduces postoperative pain and opioid demand following thyroid surgery. Can. J. Anaesth. 53 (2006) 268-273
2. Backoff P.M., Palombi P.S., and Caspary D.M. Glycinergic and GABAergic inputs affect short-term suppression in the cochlear nucleus. Hear. Res. 110 (1997) 155-163
3. Bahmad F., AR V., and Oliveira C. Benzodiazepines and GABAergics in treating severe disabling tinnitus of predominantly cochlear origin. Int. Tinnitus J. 12 (2006) 140-144
4. Bauer C.A., and Brozoski T.J. Assessing tinnitus and prospective tinnitus therapeutics using a psychophysical animal model. J. Assoc. Res. Otolaryngol. 2 (2001) 54-64
5. Bauer C.A., and Brozoski T.J. Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope 116 (2006) 675-681
6. Bauer C.A., Brozoski T.J., Holder T.M., and Caspary D.M. Effects of chronic salicylate on GABAergic activity in rat inferior colliculus. Hear. Res. 147 (2000) 175-182
7. Bone M., Critchley P., and Buggy D.J. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Reg. Anesth. Pain Med. 27 (2002) 481-486
8. Brozoski T.J., Bauer C.A., and Caspary D.M. Elevated fusiform cell activity in the dorsal cochlear nucleus of chinchillas with psychophysical evidence of tinnitus. J. Neurosci. 22 (2002) 2383-2390
9. Brozoski, T.J., Spires, T.J.D. and Bauer, C.A. (2007) Vigabatrin, a GABA transaminase inhibitor, reversibly eliminates tinnitus in an animal model. J. Assoc. Res. Otolaryngol. (available online Jan. 13).
10. Caraceni A., Zecca E., Bonezzi C., Arcuri E., Yaya Tur R., Maltoni M., Visentin M., Gorni G., Martini C., Tirelli W., Barbieri M., and De Conno F. Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J. Clin. Oncol. 22 (2004) 2909-2917
11. Caspary D.M., Holder T.M., Hughes L.F., Milbrandt J.C., McKernan R.M., and Naritoku D.K. Age-related changes in GABA(A) receptor subunit composition and function in rat auditory system. Neuroscience 93 (1999) 307-312
12. Caspary D.M., Millbrandt J.C., and Helfert R.H. Central auditory aging. GABA changes in the inferior colliculus. Exp. Gerentol. 30 (1995) 349-360
13. Hahn K., Arendt G., Braun J.S., von Giesen H.J., Husstedt I.W., Maschke M., Straube M.E., and Schielke E. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J. Neurol. 251 (2004) 1260-1266
14. Huynh L., and Fields S. Alprazolam for tinnitus. Ann. Pharmacother. 29 (1995) 311-312
15. Johnson R.M., Brummett R., and Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch. Otolaryngol. Head Neck Surg. 119 (1993) 842-845
16. Lanneau C., Green A., Hirst W.D., Wise A., Brown J.T., Donnier E., Charles K.J., Wood M., Davies C.H., and Pangalos M.N. Gabapentin is not a GABAB receptor agonist. Neuropharmacology 41 (2001) 965-975
17. Mathew N.T., Rapoport A., Saper J., Magnus L., Klapper J., Ramadan N., Stacey B., and Tepper S. Efficacy of gabapentin in migraine prophylaxis. Headache 41 (2001) 119-128
18. Milbrandt J.C., Albin R.L., Turgeon S.M., and Caspary D.M. GABAA receptor binding in the aging rat inferior colliculus. Neuroscience 73 (1996) 449-458
19. Petroff O.A., Rothman D.L., Behar K.L., Lamoureux D., and Mattson R.H. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann. Neurol. 39 (1996) 95-99
20. Rice A.S., and Maton S. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 94 (2001) 215-224
21. Ross J.R., Goller K., Hardy J., Riley J., Broadley K., A'Hern R., and Williams J. Gabapentin is effective in the treatment of cancer-related neuropathic pain: a prospective, open-label study. J. Palliat. Med. 8 (2005) 1118-1126
22. Satzinger G. Antiepileptics from gamma-aminobutyric acid. Arzneimittelforschung 44 (1994) 261-266
23. Serpell M.G. Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 99 (2002) 557-566
24. Shulman A., Strashun A.M., and Goldstein B.A. GABAA-benzodiazepine-chloride receptor-targeted therapy for tinnitus control: preliminary report. Int. Tinnitus. J. 8 (2002) 30-36
25. Shulman A., Strashun A.M., Seibyl J.P., Daftary A., and Goldstein B. Benzodiazepine receptor deficiency and tinnitus. Int. Tinnitus. J. 6 (2000) 98-111
26. Sihoe A.D., Lee T.W., Wan I.Y., Thung K.H., and Yim A.P. The use of gabapentin for post-operative and post-traumatic pain in thoracic surgery patients. Eur. J. Cardiothorac. Surg. 29 (2006) 795-799
27. Sills G.J. The mechanisms of action of gabapentin and pregabalin. Curr. Opin. Pharmacol. 6 (2006) 108-113
28. Suneja S.K., Potashner S.J., and Benson C.G. Plastic changes in glycine and GABA release and uptake in adult brain stem auditory nuclei after unilateral middle ear ossicle removal and cochlear ablation. Exp. Neurol. 151 (1998) 273-288
29. Suneja S.K., Potashner S.J., and Benson C.G. Plastic changes in glycine and GABA release and uptake in adult brain stem auditory nuclei after unilateral middle ear ossicle removal and cochlear ablation. Exp. Neurol. 151 (1998) 273-288
30. Szczepaniak W.S., and Møller A.R. Evidence of neuronal plasticity within the inferior colliculus after noise exposure: a study of evoked potentials in the rat. Electroencephalogr. Clin. Neurophysiol. 100 (1996) 158-164
31. Taylor C.P., Gee N.S., Su T.Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., and Singh L. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29 (1998) 233-249
32. Westerberg B.D., Roberson Jr. J.B., and Stach B.A. A double-blind placebo-controlled trial of baclofen in the treatment of tinnitus. Am. J. Otol. 17 (1996) 896-903
33. Wiffen P.J., McQuay H.J., Edwards J.E., and Moore R.A. Gabapentin for acute and chronic pain. Cochrane Database Syst. Rev. (Online) (2005) CD005452
34. Willott J.F., and Lu S.M. Noise-induced hearing loss can alter neural coding and increase excitability in the central nervous system. Science 216 (1982) 1331-1334
35. Witsell D.L., Hannley M.T., Stinnet S., and Tucci D.L. Treatment of tinnitus with gabapentin: a pilot study. Otol. Neurotol. 28 (2007) 11-15
36. Zapp J.J. Gabapentin for the treatment of tinnitus: a case report. Ear Nose Throat J. 80 (2001) 114-116